Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ideenat IDELALISIB 150mg Tablets
Ideenat IDELALISIB 150mg Tablets, marketed by Natco Pharma, contain the active ingredient Idelalisib. It is classified as an antineoplastic drug belonging to the class of PI3K Inhibitors.
Uses of Ideenat IDELALISIB 150mg Tablets
Ideenat IDELALISIB 150mg Tablets are used for:
Treating chronic lymphocytic leukemia (CLL) in adults, in combination with Rituximab.
Treating follicular lymphoma in adult patients as monotherapy.
Benefits of Ideenat IDELALISIB 150mg Tablets
Effective treatment option for CLL with genetic mutations like 17p deletion or TP53.
Provides therapeutic benefits in managing follicular lymphoma.
Helps in reducing cancer cell growth and progression.
Mechanism of Action of Ideenat IDELALISIB 150mg Tablets
Ideenat IDELALISIB 150mg Tablets work by inhibiting phosphoinositide 3-kinase (PI3K) delta, an enzyme involved in cell growth and survival pathways. By blocking PI3K delta, Ideenat reduces the proliferation of cancerous lymphocytes in CLL and follicular lymphoma.